Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Feb;30(1):368-370.
doi: 10.1007/s12350-022-03032-2. Epub 2022 Jul 22.

Bone scintigraphy imaging and transthyretin-related (ATTR) cardiac amyloidosis: New tricks from an old tool?

Jessica M Duran  1 , Salvador Borges-Neto  2   3
Affiliations
Editorial

Bone scintigraphy imaging and transthyretin-related (ATTR) cardiac amyloidosis: New tricks from an old tool?

Jessica M Duran et al. J Nucl Cardiol. 2023 Feb.
No abstract available

PubMed Disclaimer

Comment on

References

    1. Lane T, Fontana M, Martinez-Naharro A, et al. Natural History, Quality of Life, and Outcome in Cardiac Transthyretin Amyloidosis. Circulation. 2019;140:16–26. doi: 10.1161/CIRCULATIONAHA.118.038169. - DOI - PubMed
    1. Castaño A, Drachman BM, Judge D, Maurer MS. Natural history and therapy of TTR-cardiac amyloidosis: emerging disease-modifying therapies from organ transplantation to stabilizer and silencer drugs. Heart Fail Rev. 2015;20:163–178. doi: 10.1007/s10741-014-9462-7. - DOI - PMC - PubMed
    1. Alexander KM, Orav J, Singh A, et al. Geographic Disparities in Reported US Amyloidosis Mortality From 1979 to 2015: Potential Underdetection of Cardiac Amyloidosis. JAMA Cardiol. 2018;3:865–870. doi: 10.1001/jamacardio.2018.2093. - DOI - PMC - PubMed
    1. Gilstrap LG, Dominici F, Wang Y, et al. Epidemiology of Cardiac Amyloidosis-Associated Heart Failure Hospitalizations Among Fee-for-Service Medicare Beneficiaries in the United States. Circ Heart Fail. 2019;12:e005407. doi: 10.1161/CIRCHEARTFAILURE.118.005407. - DOI - PMC - PubMed
    1. Maurer MS, Schwartz JH, Gundapaneni B, et al. Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy. N Engl J Med. 2018;379:1007–1016. doi: 10.1056/NEJMoa1805689. - DOI - PubMed

MeSH terms